bf/NASDAQ:VRDN_icon.jpeg

COM:VIRIDIANTHERAPEUTICS

Viridian Therapeutics

  • Stock

USD

Last Close

19.62

22/11 21:00

Market Cap

783.10M

Beta: -

Volume Today

858.39K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
4.32M
-
4.32M
0.08%
2.54M
41.25%
3.34M
31.48%
4.00M
19.96%
8.39M
109.49%
4.46M
46.80%
1.05M
76.46%
2.96M
182.19%
1.77M
40.20%
314K
82.28%
cost of revenue
2.50M
-
3.24M
29.78%
2.47M
23.77%
2.55M
3.07%
1.32M
-
gross profit
1.82M
-
1.08M
40.74%
66K
93.87%
789K
1,095.45%
4.00M
407.35%
8.39M
109.49%
4.46M
46.80%
1.05M
76.46%
2.96M
182.19%
1.77M
40.20%
-1.01M
156.88%
selling and marketing expenses
378.77K
-
717K
89.30%
2.56M
256.90%
1.67M
34.78%
general and administrative expenses
1.79M
-
7.03M
293.37%
7.69M
9.35%
7.91M
2.78%
10.91M
38.02%
11.05M
1.26%
11.65M
5.40%
13.27M
13.90%
25.80M
94.53%
35.18M
36.34%
95.00M
170.02%
selling general and administrative expenses
2.17M
-
7.75M
257.70%
10.25M
32.25%
9.57M
6.59%
10.91M
13.96%
11.05M
1.26%
11.65M
5.40%
13.27M
13.90%
25.80M
94.53%
35.18M
36.34%
95.00M
170.02%
research and development expenses
96.85K
-
293K
202.54%
1.00M
241.98%
888K
11.38%
19.62M
2,109.80%
30.42M
55.03%
34.79M
14.37%
28.30M
18.65%
56.89M
100.98%
100.89M
77.36%
159.76M
58.35%
other expenses
2.83M
-
69.86M
-
cost and expenses
4.76M
-
11.29M
136.99%
13.72M
21.60%
13.01M
5.20%
30.54M
134.69%
41.47M
35.81%
46.44M
11.98%
41.57M
10.49%
82.69M
98.92%
136.08M
64.56%
254.76M
87.22%
operating expenses
2.26M
-
8.04M
255.34%
11.25M
39.89%
10.46M
7.02%
30.54M
191.84%
41.47M
35.81%
46.44M
11.98%
41.57M
10.49%
82.69M
98.92%
136.08M
64.56%
254.76M
87.22%
interest expense
1.96M
-
1.02M
47.90%
141K
86.22%
95K
32.62%
383K
303.16%
873K
127.94%
835K
4.35%
508K
39.16%
3K
99.41%
486K
16,100%
1.85M
280.04%
ebitda
-297.90K
-
-6.82M
2,190.38%
-11.00M
61.26%
-9.48M
13.80%
-26.13M
175.48%
-31.83M
21.82%
-41.04M
28.93%
-40.35M
1.69%
-79.29M
96.53%
-129.39M
63.18%
-235.37M
81.91%
operating income
-196.21K
-
-6.87M
3,399.77%
-11.19M
62.91%
-12.51M
11.81%
-26.53M
112.12%
-33.08M
24.69%
-41.98M
26.89%
-110.38M
162.94%
-79.73M
27.77%
-134.30M
68.45%
-254.45M
89.46%
depreciation and amortization
148.31K
-
144K
2.91%
184K
27.78%
189K
2.72%
308K
62.96%
281K
8.77%
941K
234.88%
70.03M
7,342.51%
438K
99.37%
4.92M
1,022.37%
522K
89.38%
total other income expenses net
250K
-
100K
60%
-141K
241%
-2.90M
1,960.28%
20K
100.69%
381K
1,805%
106K
72.18%
-335K
416.04%
315K
194.03%
4.43M
1,306.35%
16.72M
277.34%
income before tax
-2.16M
-
-7.89M
265.33%
-11.33M
43.57%
-12.67M
11.88%
-26.51M
109.18%
-32.70M
23.35%
-41.87M
28.04%
-110.72M
164.41%
-79.41M
28.27%
-129.87M
63.54%
-237.73M
83.05%
income tax expense
1.96M
-
1.02M
47.90%
95K
-
95K
0%
1.25M
1,220%
547K
56.38%
269K
50.82%
3K
98.88%
-4.43M
147,766.67%
18.56M
519.03%
net income
-2.16M
-
-7.89M
265.33%
-11.33M
43.57%
-12.67M
11.88%
-26.51M
109.18%
-32.70M
23.35%
-42.42M
29.71%
-110.98M
161.63%
-79.42M
28.44%
-125.44M
57.96%
-237.73M
89.51%
weighted average shs out
12.54K
-
10.03K
20.05%
35.96K
258.71%
48.09K
33.73%
1.28M
2,567.65%
1.97M
53.81%
2.09M
5.87%
3.56M
70.27%
11.92M
235.07%
32.09M
169.22%
44.76M
39.48%
weighted average shs out dil
12.54K
-
10.03K
20.05%
35.96K
258.71%
48.09K
33.73%
1.28M
2,567.65%
1.97M
53.81%
2.09M
5.87%
3.56M
70.27%
11.92M
235.07%
32.09M
169.22%
44.76M
39.48%
eps
-172.21
-
-786.95
356.97%
-314.98
59.97%
-263.53
16.33%
-20.66
92.16%
-16.57
19.80%
-20.31
22.57%
-31.20
53.62%
-6.66
78.65%
-3.91
41.29%
-5.31
35.81%
epsdiluted
-172.21
-
-786.95
356.97%
-314.98
59.97%
-263.53
16.33%
-20.66
92.16%
-16.57
19.80%
-20.31
22.57%
-31.20
53.62%
-6.66
78.65%
-3.91
41.29%
-5.31
35.81%

All numbers in USD (except ratios and percentages)